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Abstract
Background Aortitis is a subtype of the more general term
“vasculitis”, an inflammatory condition of infectious or
noninfectious origin involving the vessel wall. The term
“vasculitis” refers to a broad spectrum of diseases with
different aetiologies, pathophysiologies, clinical presenta-
tions and prognoses. The clinical manifestations are nonspe-
cific, as are the laboratory findings such as pain, fever,
weight loss, vascular insufficiency and elevated levels of
acute phase reactants, as well as other systemic manifesta-
tions, and sometimes may mimic other entities. Thus, if not
suspected as part of the initial differential diagnosis, aortitis
can be overlooked during the workup of patients with con-
stitutional symptoms and systemic disorders. Methods: Im-
aging is rarely used for the primary diagnosis, but imaging
findings, although nonspecific, can help in the assessment of
these patients and is often required for making the final
diagnosis. Imaging can be critical in the initiation of appro-
priate management and therapy. Results: Noninvasive cross-
sectional imaging modalities such as contrast-enhanced CT,
magnetic resonance (MR) imaging, nuclear medicine and in
particular positron emission tomography (PET) are the lead-
ing modalities in modern diagnostic imaging of aortitis for
both the initial diagnosis and follow-up. Conclusion: This
review focusses on the most common manifestations of
aortitis with which radiologists should be familiar.
Teaching Points
￿ Aortitis is an inflammatory condition of infectious/nonin-
fectious origin involving the vessel wall.
￿ Imaging findings can help in the assessment of aortitis and
are often crucial for the final diagnosis.
￿ Contrast-enhanced CT, MRI and PET-CTare used for both
the initial diagnosis and follow-up of aortitis.
Keywords Aortitis .Vasculitis .MDCT .MR .PET-CT
Introduction
Vasculitis refers to a varied group of rare disorders that all
share underlying inflammation of the vasculature [1, 2]. The
inflammationcanaffectbloodvesselsofanysize,botharteries
and veins, in any location of the body [1]. The inflammation
may be focal, affecting a single anatomical level within a
vessel, or it may be widespread, with areas of inflammation
scattered throughout the entire vascular bed of a particular
organ,ormayevenaffectmorethanoneorgansystem[3].The
inflammation may be infectious or noninfectious, the latter
b e i n gm o r ec o m m o n[ 1]. In the thorax, noninfectious inflam-
matory vasculitis can affect large vessels such as the aorta and
the pulmonary arteries, with diseases such as Takayasu arter-
itis, giant cell arteritis (GCA) or Behçet's disease [4]. Medium
and small vessels can be involved in the context of collagen
vascular disorders such as rheumatoid arthritis, ankylosing
spondylitis, relapsing polychondritis or systemic lupus eryth-
ematosus [5]. Infectious involvement caused by tuberculosis,
syphilisorSalmonellaispossiblebutlesscommonunlesspre-
existing aortic wall damage is present [6]. The main aetiolo-
gies for vasculitis in the thorax are summarised in Table 1.
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DOI 10.1007/s13244-012-0192-xAlthough imaging is seldom used for primary diagnosis
of thoracic large vessel vasculitis, it plays an important role
in differentiating between infectious and noninfectious vas-
culitis, as well as monitoring disease activity or guiding
biopsy. Another important role of imaging is to exclude
alternative diagnoses for the clinical presentation of patients
[1, 5, 7].
T h em o s tc o m m o n l yu s e di maging modalities in the
workup of thoracic large vessel vasculitis are CT, MRI and
ultrasound, including transoesophageal echo [7]. There is
also a growing role for positron emission tomography [5].
The aim of this article is to present both the techniques used
to assess thoracic large vessel vasculitis and to detail the
particular findings characteristic for those diseases.
Imaging techniques
Althoughnosinglespecificexaminationprotocoloralgorithm
exists for the assessment of potential vasculitis, the main
purpose of imaging is to assess vessel wall and vessel lumen
morphology using similar protocols for initial assessment and
follow-up for adequate comparison. Note that the protocols
used for CTor MRI are similar to those used for evaluation of
acute aortic syndrome or pulmonary embolism [7].
It must, however, be emphasised that imaging is only one
of many other tools available for the diagnosis of vasculitis,
such as gene analysis, family studies, clinical assessment,
biopsy, histology and immunochemistry [1].
CT technique
CT is used for the assessment of aortic wall thickness and
regularity, aortic diameter, mural calcifications and aortic
branches. Bi-phasic CT is typically performed, including
non-enhanced CT of the chest (40 mA, 100 kVp) [8]. The
non-enhanced scan is used to exclude intramural haematoma
and to show intramural calcification, particularly in cases of
long-standing vasculitis. Therefore, it can be omitted in
patients younger than 40 years of age. A contrast-enhanced
scan of both the aorta and pulmonary arteries is typically the
second step in the aortic assessment. Automatic exposure
modulation controlling the tube current with an mA range of
200–500 and kilovoltage setting of 100 kVp is recommended
for adequate assessment of the thoracic aorta [9]. To enhance
the aorta and pulmonary arteries simultaneously, triggering at
the level of left atrium is recommended with an injection rate
of not less than 4 ml/s, and an overall injection of at least
1 0 0m lo fI Vc o n t r a s ti sr e q u i r e d[ 8]. ECG-gated CTA can be
considered for better imaging of the ascending aorta [10].
Transverse images in conjunction with coronal, sagittal and
curved reformats are helpful for assessment of the extent and
severity of vessel wall involvement. CTangiography can also
be used as a follow-up tool to assess the treatment response
and/or activity of the disease [5].
MRI technique
Similar to CT, MRI provides excellent assessment of the
vascular wall and lumen with multiplanar and three-
dimensional reformations, with the advantage of using no
ionising radiation. This is the modality of choice for follow-
up, particularly in young patients. Even when gadolinium
cannot be administered because of impaired renal function,
assessment of the vessel can be done with MRA techniques.
A more detailed description of the findings and technique
will be given while discussing specific aortitis entities.
Nuclear imaging
18-FDG-PET-CT is playing an increasing role in assessing
inflammatory changes such as vasculitis, atherosclerosis and
acute dissection in the aorta and pulmonary arteries [1, 11].
As opposed to FDG PET assessment of cardiac disease
where adjustment of the protocol is required because of
radiotracer accumulation in normal myocardium, FDG does
not accumulate in normal vascular structures. Thus, any
uptake of 18-FDG in the aortic wall is abnormal because
of inflammatory or infectious processes [11], and no specific
protocol is needed for assessing vasculitis with PET-CT
[11]. Although inflammatory activity is well appreciated
on images, morphologic assessment is limited because of
the relatively low special resolution; thus, nuclear imaging
studies receive substantial benefit when obtained in con-
junction with either CT or MRI, increasing the sensitivity
and specificity of this test [12–14].
Noninfectious aortitis
As previousy stated, vascular inflammation in aortitis is pre-
dominantly noninfectious. The vast majority of noninfectious
Table 1 Classification of aortitis
Types of aortitis
Noninfectious aortitis Infectious aortitis
Most common aetiologies Most common aetiologies
Takayasu arteritis Pyogenic infection
Giant cell arteritis Tuberculous aortitis





546 Insights Imaging (2012) 3:545–560aortitis cases are associated with rheumatic disease such as
Takayasu arteritis, GCA, long-standing ankylosing spondyli-
tis, Cogan syndrome (interstitial keratitis, iritis, conjunctival
or subconjunctival haemorrhage, fever, aortic insufficiency)
or relapsing polychondritis, with aortitis seen in more than
10 % of cases (Table 2)[ 15]. There is also a less frequent but
well-documented association between aortitis and rheumato-
logic problems present in rheumatoid arthritis, seronegative
spondyloarthropathies,Behçet'sdiseaseandSLE[5].Sarcoid-
osis, Wegener's granulomatosis, polyarteritis nodosa and ju-
venile rheumatoid arthritis have also been associated with
sporadicreports ofaortic involvement [5].Symptomsofpoly-
myalgia rheumatica have been reported in approximately
10 % of patients with noninfectious ascending aortitis [16].
Takayasu arteritis
Takayasu arteritis (TA) is a necrotising and obliterative
segmental, large-vessel panarteritis of unknown cause, in-
volving elastic arteries including the aorta and its branches.
T-cell-mediated panarteritis starts in the adventitial vasa
vasorum and progresses inwards, with the unknown antigen
triggering monoclonal T-cell expansion [1, 17]. This inflam-
matory process begins with perivascular cuffing of the vasa
vasorum in the early stage of the disease followed by fibro-
sis and calcifications [18]. Destruction and fibrosis coexist
with the former, causing aneurysmal formation and the latter
leading to narrowing of the aorta and its branches, resulting
in significant stenosis. Takayasu artertitis is also known as
“pulseless disease” from the frequent involvement of sub-
clavian arteries with substantial stenosis and subsequently
diminished peripheral pulses [5].
This idiopathic process has a strong female predilection,
affecting females ten times more than men [19]. The peak
incidence is in the 3rd decade of life, but age spans from late
childhood to the 5th decade have been reported [19]. The
overall rate in the US is 2.6 cases per 1 million persons, with
moderate Asian over-representation [1]. Two specific dis-
ease distributions have been reported, Japanese and Indian.
In the Japanese group, the predilection is toward the thoracic
aorta and its branches, as opposed to the Indian group,
where the abdominal aorta and renal arteries are most af-
fected [3].
Clinical presentation
Two phases, early acute and late chronic, are seen in TA. In
the early phase, so-called “B” symptoms, such as weight
loss, fatigue, night sweats, anorexia and malaise, are com-
mon [17]. Chronic phase symptoms are determined by the
organs involved, with fewer constitutional symptoms, and
with claudication, cerebrovascular insufficiency, carotid ar-
tery pain and renal artery involvement most frequently
reported [17]. Hypertension due to renal artery involvement
is particularly frequent among the Indian population [20].
Aortic aneurysm or stenosis has been reported in up to
one-third of the cases [21]. In the order of frequency, aneu-
rysmal formation is seen in descending, abdominal and
ascending aortic segments. Stenosis of the aorta is even
more frequent, occurring in 53 % of cases based on a
National Institutes of Health series, mostly affecting the
abdominal aorta (up to 70 % of aortic stenosis cases) [1].
Diagnosis
Takayasu arteritis is diagnosed based on the 1990 American
College of Rheumatology criteria [22] (Table 2).
(1) Age of onset younger than 40 years
(2) Intermittent claudication
(3) Diminished brachial artery pulse
(4) Subclavian artery or aortic bruit
(5) Blood pressure difference greater than 10 mmHg
(arms)
(6) Angiographic (CT, MR) evidence of stenosis
If three out of six criteria are present, the sensitivity and
specificity for the diagnosis according to these criteria are
90 % and 98 % respectively. Laboratory tests such as eryth-
rocyte sedimentation rate and C-reactive protein are elevat-
ed in 70 % of patients in the acute and 50 % of patients in
the chronic stage of the disease [1].
Imaging findings
All clinically available imaging modalities play an important
rolein the diagnosis and follow-up ofTA. Until recently, digital
subtraction angiography (DSA) was the procedure of choice,
but this has been subsequently replaced by cross-sectional
imaging [23] as the major disadvantages of DSA are the high
radiation dose, substantial contrast material burden and diffi-
culty in assessing cases of long-segment stenosis and aortic










Polyarteritis nodosa, juvenile rheumatoid arthritis, Cogan
syndrome—rare
Insights Imaging (2012) 3:545–560 547wall abnormalities such as arterial calcification, wall inflamma-
tion or chronic fibrosis [5]. Additionally, transoesophageal
echocardiography and intravascular US are tools that provide
high-resolution images of subtle changes in aortic segments
that may appear normal with other imaging techniques, al-
though usually only the proximal aorta can be assessed [18].
1. Computer tomography
Acute stage:
The vast majority of TA cases are diagnosed with CT
angiography (CTA) since CTA can depict early findings
in the vessel wall and lumen, such as circumferential
vessel wall thickening, thrombosis, stenosis, occlusion,
vessel ectasia, aneurysms and ulcers (Figs. 1, 2, 3, and
4)[ 19, 24]. The “double ring” appearance of the thick-
ened aortic wall at contrast-enhanced CT is an early
stage finding with a poorly enhanced internal ring of
swollen intima and an enhancing outer ring of the in-
flamed media and adventitia [5, 24].
That milder degrees of inflammation or wall oedema
may not be apparent with CTA is of note. It is consid-
ered less sensitive than other modalities such as MR or
PET-CT for evaluating the degree of inflammation in
the aortic wall [25].
Since CTA is performed using iodinated contrast, it
offers the additional advantage of allowing rapid exclu-
sion of aortic pathologies that may clinically mimic
acute aortitis, including aortic dissection, intramural
haematoma and penetrating atherosclerotic ulcer.
Chronic stage:
Chronic findings include long-standing, burned out
aortitis such as linear arterial wall calcification that can
be seen after a minimum of 5 years of inflammatory
involvement in the aorta or any of the involved vessels,
except the ascending aorta [5, 24]. CT can also be used
to assess the progression of a potential thoracic aortic
aneurysm [1]. High specificity and sensitivity of CT
angiography (95 % and 100 %, respectively) [26]a s
well as high availability make it the imaging modality of
choice for the evaluation of TA.
Although ionising radiation is of concern, new CT
low-dose techniques focussing on decreased kilovoltage
and novel reconstruction algorithms provide substantial
dose reduction and should be considered, especially
when patients are young [27].
2. Magnetic resonance imaging
A major strength of MR imaging is its ability to
depict wall abnormalities before luminal changes occur
[28]. Gadolinium-enhanced fat-suppressed T1-weighted
images are preferred to assess thickening and enhancing
of the arterial wall and T2-weighted images for showing
high signal of the vessel wall representing mural oede-
ma (Figs. 5 and 6). MR angiography may show stenosis
at multiple levels, mural thrombi, thickening of aortic
valve cusps and pericardial effusions [18, 28–30]. Sig-
nal alterations within the pericardial effusion, reflecting
Fig. 1 a–c A 25-year-old pre-
viously healthy man with chest
and abdominal pain, weight
loss and low grade fever. Axial
(a), sagittal (b) and coronal (b)
images of CTA of the torso
demonstrate circumferential
wall thickening of both the as-
cending and descending tho-
racic aorta as well as aortic wall
thickening including in the ab-
dominal aorta (white arrows).
Diffuse narrowing of the aorta
can be appreciated on all three
views. Courtesy of Dr. Eduard
Ghersin, Jackson Memorial
Hospital, Miami, Florida
548 Insights Imaging (2012) 3:545–560fluid and granulation tissue, can be seen as well [18].
Cine MRI can detect cardiovascular and haemodynamic
changes, such as aortic regurgitation in patients with TA
[31]; MR angiography demonstrates the anatomical lo-
cation, degree, extent of stenosis and vascular dilation,
and patency of collateral vessels and surgical bypass
grafts.
Both contrast-enhanced MRI and CTA play an im-
portant role in the early diagnosis of TA, i.e., by dem-
onstrating crescentic or ring-like aortic thickening of
more than 3 mm, as well as for assessing disease activity
[32].
Limitations of MR angiography include the possibil-
ity that vascular branch points may be improperly inter-
preted as occlusions (breath-hold techniques have
lessened this problem) and that maximum-intensity pro-
jection images may falsely accentuate the degree of
vascular stenosis [5]. It is therefore advisable to assess
the degree of vascular stenoses from the MR angiogra-
phy source images [18]. Additional drawbacks of MRI
are the relatively decreased sensitivity in the assessment
of small vessels and poor visualisation of vascular cal-
cifications, as well as the limited anatomical range that
can be scanned as opposed to CT. Finally, MRI is
commonly less available in the geographic regions
where TA is most prevalent [18].
3. Nuclear imaging
PET-CT may help to identify vasculitis in patients
referred for whole-body imaging for constitutional symp-
toms and fever of unknown origin, as well as to monitor
treatment response [11]. The circumferential region of
increased metabolic activity in the vessel wall is charac-
teristic of the active phase of TA (Fig. 7). FDG-PET has a
reported sensitivity of up to 92 % and a specificity of 89–
100 % for the detection of large vessel vasculitis among
untreated patients with elevated serum markers [33]. Re-
cently, the use of18-fluorodeoxyglucose (18F-FDG) PET,
either alone or in combination with contrast-enhanced
CTA or MRA, has emerged as a potential tool for the
initial diagnosis and assessment of disease activity of
aortitis caused by Takayasu arteritis with a variable sensi-
tivity of 60–90 % and specificity of 88–100 % [24, 13, 12,
34]. PET-CT may also be useful for monitoring treatment
response, reflected in decreases in vessel wall metabolic
activity [35]. However, the main limitations of these stud-
ies are the small sample size, heterogeneous patient pop-
ulation and inconsistent reference standards [36].
Hybrid imaging with 18F-FDG PET and either
CTA or MRA allows more precise anatomic local-
isation of disease activity with increased uptake of
18F-FDG thought to be a surrogate marker of in-
creased activity of inflammatory cells. The presence
Fig. 2 a–c 20-year-old previ-
ously healthy woman with chest
pain. CTA of the lower neck
demonstrates circumferential
wall thickening of the left ca-
rotid artery (a). Ascending aorta
is dilated with circumferential
wall thickening (b).
Gadolinium-enhanced sagittal
(c) view demonstrated dilata-
tion of both ascending and
descending thoracic aorta as
well as aortic wall thickening
including in the abdominal
aorta
Insights Imaging (2012) 3:545–560 549of wall thickening, arterial stenosis, luminal throm-
bus and aneurysm cannot be assessed by PET alone;
C T Aa n dM R Aa r ec o m p l e m e n t a r yt oP E Tf o rc o m -
plete evaluation of the patient with aortitis [24].
Complications and therapy
To prevent the known complications of TA such as stenosis,
aneurysm formation or occlusion, early treatment with cor-
ticosteroids is indicated to suppress inflammatory response.
The usual regimen includes high-dose oral steroids (40–
60 mg daily), usually for as long as 1–2 years. Unfortunate-
ly, up to 50 % of patients relapse during tapering and require
additional immunosuppression. Serum markers have limited
value in follow-up since disease progression has been
shown in the presence of normal serum marker levels [17].
Revascularisation in cases of aortic stenosis or aneurysm
is performed when there is secondary vascular organ insuf-
ficiency or risk of rupture. Usually the intervention is done
in chronic cases after the acute phase inflammation has
subsided. Currently, there are no randomised trials of per-
cutaneous or surgical intervention [24].
Giant cell arteritis
Giant cell arteritis (GCA), also known as temporal arteritis,
is an elastic vessel systemic granulomatous vasculitis affect-
ing the aorta as well as its secondary and tertiary branches
(large and medium-sized vessels) and usually involves
Fig. 4 A 36-year-old male with abdominal pain and weight loss over
the last 3 months. MDCTA of the abdomen demonstrates diffuse
thickening of the aorta and superior mesenteric artery (SMA) with
substantial narrowing of the SMA lumen (arrow). Courtesy of Dr.
Ludmila Guralnik, Rambam Health Care Campus, Haifa, Israel
Fig. 3 a–d A 48-year-old
woman with weight loss, mal-
aise and headaches. Axial (a, b)
CTA images demonstrate con-
centric thickening of the bra-
chiocephalic artery, continuing
toward its branches: right com-
mon carotid artery, right sub-
clavian artery and left
subclavian artery (originating
from the brachiocephalic artery
in this case). Multiplanar
curved reformats (c, d) demon-
strate both wall thickening and
aneurysmal dilatations along
the course of both common ca-
rotid arteries (c right, d left) and
brachiocephalic artery trunk (c).
Courtesy of Dr. Ludmila
Guralnik, Rambam Health Care
Campus, Haifa, Israel
550 Insights Imaging (2012) 3:545–560superficial cranial arteries. Aortic involvement occurs in
15 % of GCA patients [37]. As opposed to predominately
young patients affected by TA, GCA is usually seen in
patients over 50 years old with an incidence peaking in the
8th decade of life [38]. Female predilection is less frequent
(3:2 female:male ratio). A higher than usual incidence of
disease is seen in Northern Europe (Scandinavia in particu-
lar), with lesser frequency in Southern Europe, making
genetic predisposition in certain populations likely [1].
Overall, GCA is the most common form of aortitis in North
America, accounting for more than 75 % of cases [37]. A
strong relationship between GGA and polymyalgia rheuma-
tica has been shown.
Clinical presentation
GCA acute and chronic stage pathophysiology is similar to
TA [5]. During the acute stage constitutional symptoms such
as weight loss, night sweats, malaise and fever are extremely
common, affecting half of the patients. In up to 90 % of
patients with biopsy-proven disease, scalp tenderness is
present. Cranial symptoms (tenderness, headache), jaw clau-
dication, visual changes and neurologic changes are all
commonly seen [1].
Vascular inflammation most commonly involves external
carotid branches, especially the superior temporal artery and
the vertebral arteries. Extracranial arteries are involved in
25 % of cases such as the aorta, coronary arteries and
mesenteric arteries [39]. Five-year survival can be affected
in cases of widespread disease [40]. Aortic stenosis is less
common than in TA [41], although annuloaortic ectasia or
ascending aortic aneurysms that can extend into the aortic
arch are more common than in TA [42–44]. Thoracic aortic
aneurysms are usually seen in the late stages of the disease.
Diagnosis
GCA is diagnosed based on the 1990 American College of
Rheumatology criteria where three out of five criteria are
required for diagnosis, with sensitivity of 94 % and speci-
ficity of 91 % [1, 38].
& Age older than 50 years
& Recent-onset localised headache
& Temporal artery pulse attenuation or tenderness
& Erythrocyte sedimentation rate > 50 mm/h
& Arterial biopsy: necrotising vasculitis
& No imaging findings are required for diagnosis
Imaging findings
CT, MRI, PET-CT and ultrasound Although no imaging
findings are required for diagnosis, imaging might be help-
ful in diagnosing GCA. Long segment involvement with
significant wall thickening and smooth tapering proximal
and distal to the lesion on CT and MR are classic radiolog-
ical findings. The most frequently affected arteries are the
subclavian, axillary, femoral, popliteal, tibial and peroneal,
with rare involvement of coronary arteries [45]. CT and in
particular MR angiography are able to demonstrate vessel
wall oedema, which reflects disease activity [46]. CT angi-
ography can reveal luminal changes similar to TA such as
stenosis, occlusion, dilatation, aneurysm formation, calcifi-
cation and mural thrombi [47].
a c
d b
Fig. 5 a–d A 51-year-old male
with chest pain. Spin-echo T1-
weighted (a), post-gadolinium
enhanced (b) and proton densi-
ty (c) images of the aortic arch
show diffuse and relatively
uniform thickening of the aortic
arch with focal aneurysmal di-
latation of the posterior aspect
of the distal arch (arrow). Vivid
gadolinium enhancement is
uniform and diffuse (b), being
even more vivid at the mid-
outer portion of the aortic wall
(d), corresponding to a “double
ring” appearance
Insights Imaging (2012) 3:545–560 551An association between history of GCA and the
development of aortic aneurysm has been described,
particularly thoracic aortic aneurysm [41]. The frequen-
cy of aortic involvement in GCA is unknown, but it has
been suggested that all patients with temporal GCA and
symptoms of extracranial vascular involvement undergo
an imaging study to evaluate the aorta and large tho-
racic vessels [48].
FDG PET has been shown to be sensitive for extracranial
vasculitis but not for intracranial vasculitis on account of its
poor spatial resolution [49]. FDG PET reveals abnormal







Fig. 6 a–g A 63-year-old man
with a prolonged history of
Takayasu arteritis. MDCTA ax-
ial images of the chest at the
level of the main and left pul-
monary artery (a), right pulmo-
nary artery (b, c) and right
upper lobe demonstrate sub-
stantial thickening of the pul-
monary arterial wall, especially
pronounced at the level of the
right pulmonary artery with al-
most complete occlusion of the
right upper lobe branch and
pulmonary infarcts (d)
(arrows). T1-weighted (e), T2-
weighted (f) and GD-enhanced
(g) MRI images emphasise the
same findings as well as sub-
stantial wall oedema seen as
bright signal on T2-weighted
images (f)( arrows)
552 Insights Imaging (2012) 3:545–560than half of affected patients (sensitivity 56 %, specificity
98 %, positive predictive value 93 %, negative predictive
value 80 %) [11, 50].
Ultrasonography is useful in assessing cranial vessels,
showing an increased diffuse, circumferential intima-media
complex (IMC) thickness in transverse sections (dubbed the
‘macaroni sign’), reflecting inflammatory oedema, in-
creased vascularity or both. In contrast, atherosclerotic
lesions are usually characterised by a localised thick IMC
pattern [7].
Complications and therapy
Aortic aneurysm complicated by acute dissection or aortic
valve insufficiency is associated with decreased survival (on
average 1.1 years) [41]. The standard therapy, high-dose
oral steroids (40–60 mg daily) for 1–2 years, results in rapid
improvement but a high relapse rate. Unlike TA, additional
immunosuppressive therapy does not affect the course of the
disease, but the approach to revascularisation is similar to
TA [1, 48].
Behçet's disease
Behçet's disease is a chronic multisystemic and relapsing
inflammatory disorder seen particularly in young males. The
clinical triad is recurrent oral and genital ulcers, and uveitis
was originally described by the Turkish dermatologist
Hulusi Behçet in 1937 [51] . The disease is most frequently
seen in the Mediterranean region, Middle East and Far East.
The highest prevalence (80–370 per 100,000) was reported
in Turkey [52] but it is now increasing in other parts of the
world, especially Europe and America, because of migra-
tion. A significant association between HLA-B51 and the
risk of developing Behçet’s disease supports a genetic pre-
disposition to the disease [53].
Diagnosis
The diagnosis is made on the basis of the criteria established
by the International Study Group for Behçet’s Disease. The
diagnostic criteria require the presence of oral ulceration and
at least two of the following: recurrent genital ulceration,
eye lesions (anterior and posterior uveitis and retinal vascu-
litis), skin lesions (erythema nodosum, pseudofolliculitis,
papulopustular lesions and acneiform nodules) or a positive
pathergy test (development of an erythematous papule or
pustule 48 h after a needle prick to the skin) [54].
Imaging fındings
Multidetector CTangiography (MDCTA) plays a critical role
in the noninvasive assessment of various types and sites of
vascular involvement and associated parencyhmal and pleural
changes, as well as preoperative treatment planning, because
of its multiplanar and vascular reconstruction capabilities
(Figs. 7, 8, 9 and 10)[ 55]. The frequency of vascular involve-
ment in Behçet’s disease is only 25–30 %, but it is the most
common cause of mortality [56, 57]. Histopathologically,
leukocytoclastic vasculitis is seen in Behçet’sd i s e a s e .T h e
vasculitic process results in inflammation that leads to occlu-
sion, thrombus and aneurysm formation. The vasculitis can
involve various sized arteries and veins (large, medium and
small)ofthesystemicandpulmonarycirculation[52,58].The
small vessel involvement affects the skin, joints, central ner-
vous system and gastrointestinal tract and may result in non-
vascular complaints such as erythema nodosum, arthritis,
demyelination and gastrointestinal involvement with diar-
rhoea, gastrointestinal bleeding or perforation [59, 60].
While arterial involvement is rare, the artery most often
affected is the aorta followed by the pulmonary arteries. Al-
though rare, aortic arch branches such as coronary arteries and
extremity arteries can also be involved. Aneurysm formation
Fig. 7 a–c A 59-year-old woman with low-grade fever, malaise and
high white blood cell count. Axial (a) CTA image demonstrates normal
thickness (arrowhead) of the ascending aortic wall with minimal
thickening of the descending aortic wall (arrow). Axial contrast-
enhanced MR image (b) shows contrast in the ascending and descend-
ing aortic wall corresponding to vivid 18-FDG uptake on PET-CT
image (c)
Insights Imaging (2012) 3:545–560 553occurs more commonly than occlusion. Histopatologically,
inflammation of the vasa vasorum that leads to destruction of
the elastic fibres of the tunica media causing aneurysm, pseu-
doaneurysm formation and rupture is seen [61]. Behçet's dis-
ease is the most common cause of pulmonary artery aneurysm
(Fig.11)[62].Patientswithpulmonaryarterialaneurysmshave
a poor prognosis. Thrombosis of the pulmonary arteries
is commonly in situ. Although deep vein thrombosis is
common, the risk of developing pulmonary emboli is
very low because the thrombi are strongly attached to
the vasculitic veins. [55].
In Behçet's disease venous manifestations are more com-
mon than arterial involvement. Superficial venous thrombo-
phlebitis is the most frequent venous involvement. Deep vein
thrombosis affects the veins of the lower extremities most
commonly, followed by superior vena cava, inferior vena cava
andupperextremity involvement. Cerebral venous thrombosis
m a ya l s ob es e e ni nB e h ç e t ' sd i s e a s e[ 59]. Venous aneurysms
and varices are rarely seen in Behçet disease [63]b u ts u p e r i o r
vena cava (SVC) thrombosis is well known. Thrombosis of
adjacent large veins such as the brachiocephalic, subclavian
andaxillaryveinsmayaccompanySVCthrombosis.Collateral
veins are seen in chronic stage SVC thrombosis in the neck,
mediastinum and chest wall (Figs. 12 and 13)[ 64]. SVC
syndrome due to vasculitis that results in thickening of the
vessel wall without evidence of thrombosis may also be seen.
The main cause of sudden death in Behçet's disease is
rupture of a large aortic or arterial aneurysm.
Hughes-Stovin syndrome
Hughes-Stovin syndrome is characterised by pulmonary arteri-
al aneurysms and systemic venous thrombosis. Hughes-Stovin
syndrome is also known as “incomplete Behçet's disease”
because of similarities between the vascular manifestations of
Behçet's disease and Hughes-Stovin syndrome [59, 65].
Complications and therapy
A combination of corticosteroids and cytotoxic agents is used
for patients with arteritis. Anticoagulant therapy for deep
venous thrombosis should be given carefully in patients with
pulmonary arterial aneurysms because of the risk of potential-
lyfatalhaemoptysis.Surgicaltreatmentmaybeconsideredfor
large vessel disease refractory to medical treatment [66–68].
Anastomotic pseudoaneurysms and recurrence often occur in
surgical repair. Endovascular intervention with a stent graft is
an effective alternative to surgery [69].
Ankylosing spondylitis
Ankylosing spondylitis is part of group of diseases called “spon-
dyloarthropathies” that have a strong association between major
histocompatibility complex HLA B-27 and the absence of rheu-
matoid factor. Common features of the disease are sacroilitis,
inflammatory arthritis or enthesitis, and association with
Fig. 8 a, b A 40-year-old male
with Behçet's disease. Sagittal
maximum-intensity-projection
CT image (a) shows a saccular
aneurysm arising from the distal
thoracic aorta (arrows). Coronal
maximum-intensity-projection
CT image (b) shows saccular
aneurysm arising from the left
subclavian artery (white
arrows)
Fig. 9 A 24-year-old male with Behçet's disease. Axial CT image
shows ruptured pseudoaneurysm of the left anterior descending coro-
nary artery (white arrow) with accompanying haematoma (white
asterisk)
554 Insights Imaging (2012) 3:545–560inflammatory bowel disease or psoriasis. This is the first rheu-
matic disease found to be associated with aortitis, seen in up to
80 % of patients with AS, in particular aortic root involvement
and aortic valve disease [70]. More than half of the patients
demonstrate aortic wall thickening [71]. Since aortic valve in-
volvement isassociatedwithvalvularinsufficiency,itcanleadto
heart failure and death. Heart block has been described as part of
the disease because of extension of the subaortic fibrotic process
into the interventricular septum causing conduction abnormali-
ties (second common cardiovascular manifestation occurring in
AS patients) [71]. The frequency of aortic insufficiency and
regurgitation parallels that of the duration of the disease [71].
Clinical presentation
Ankylosing spondylitis, the most common variant of
spondyloarthropathies, often begins with back pain and
stiffness during the second or third decade of life.
Contrary to TA and GCA, it affects men two to three
times as often as women. Disease usually worsens with
inactivity. Constitutional symptoms (malaise or fever) as
well as acute anterior uveitis (up to 40 % of patients)
are common features [71]
Diagnosis
Diagnosis of AS requires four of the five criteria.
& Onset of pain at age younger than 40 years
& Back pain for longer than 3 months
& Morning stiffness
& Subtle symptom onset and
& Improvement with exercise
& No imaging findings are required for diagnosis
Fig. 10 A 34-year-old male with Behçet's disease. 3D colour-coded
volume-rendering CT image shows pseudoaneurysm of the superficial
femoral artery
Fig. 11 a, b A 23-year-old male with Behçet's disease. Axial (a),
sagittal reformatted (b) contrast-enhanced CT images show partially
thrombosed right pulmonary artery aneurysm (arrow)
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Because the aortic root and aortic valve are most commonly
affected, all three modalities, echocardiography, MR imag-
ing and CT angiography, are useful for diagnosis. Nodular
appearance of the aortic valve and presence of aortic regur-
gitation are better seen with echocardiography. Involvement
of coronary arteries is rare but can be seen with CTcoronary
angiography. Imaging is also useful for pre-surgical plan-
ning in cases of aortic root expansion or aortic valvular
malfunction [70, 71].
Aortitis in association with other rheumatologic disorders
Additional rheumatic diseases associated with aortitis are:
relapsing polychondritis (RP), rheumatoid arthritis (RA),
systemic lupus erythematosus and Cogan's syndrome, with
RP and RA being relatively more frequently described.
Relapsing polychondritis
Relapsing polychondritis can affect the elastic elements of
the cardiac valves and aorta as part of the multisystem
inflammatory autoimmune disorders represented by aortic
root dilatation and aortitis. The prevalence of cardiac in-
volvement is 15–45 % and includes aortic dilatation, with
secondary regurgitation, mitral regurgitation and aortitis
caused by cystic degeneration of collagen, destruction of
elastic fibres, lymphocytic infiltration and decreased acid
mucopolysaccharide content [72].
The acute and chronic phases of relapsing polychondritis
are similar to those seen in TA and GCA, although the entire
aortic wall is involved as opposed to primarily the media
and adventitia [73]. Aortic wall calcification and ossification
with nodular wall formation have also been described [74]
as well as aneurysm formation in the thoracic and abdominal
aorta (5 % of cases) and vasculitis obliterans in medium-
sized and large arteries [75, 76].
Rheumatoid artritis
Aortitis is rare in RA, which is seen in about 5 % of cases
with even less frequent aneurysm formation [77]. The aortic
Fig. 13 A 31-year-old male with Behçet's disease. Coronal maximum-
intensity projection CT image (a) shows thrombosed left lower lobe
pulmonary artery aneurysm (arrow) and pleural-based, wedge-shaped
infarction (arrowhead). Axial CT image (b) also shows a thrombosed
left lower lobe pulmonary arterial aneurysm (arrow)
Fig. 12 A 20-year-old male with Behçet's disease. Sagittal reformatted
CT image shows superior vena cava thrombosis (black arrows) and
collateral vessels in the mediastinum and chest wall (white arrows)
556 Insights Imaging (2012) 3:545–560valve and annulus may also be affected by granulomatous or
nongranulomatous inflammation, leaflet thickening and sec-
ondary regurgitation [78]. Involvement of the coronary os-
tia, if present, may lead to myocardial ischaemia [15]. Life-
long therapy with corticosteroids carries the risk of sponta-
neous rupture of pre-existing, possibly multiple, aortic
aneurysms [79, 80].
Idiopathic isolated aortitis
This is a rare form of aortitis complicated by a lack of any
known systemic disease. It may present with symptoms relat-
ed to aortic inflammation such as back pain, abdominal pain
and/or elevated inflammatory markers, and both the thoracic
and abdominal aorta can be involved. Incidental diagnosis is
also possible [24]. Usually silent, it is complicated by the
formation of aneurysms in the thoracic aorta or abdominal
aorta, where up to 10 % of all aortic aneurysms might be
attributed to inflammatory aortitis. A combination of thoracic
and abdominal aneurysms is also possible [24]. Idiopathic
inflammatory aneurysms differ from atherosclerotic aneur-
ysmsbecauseofthepresenceofdenseperianeurysmalfibrosis
and a thickened aortic wall [81]( F i g .14). Acute renal failure
caused by ureterine obstruction has been reported in patients
withretroperitoneal fibrosis,partofthe spectrumofidiopathic
Fig. 14 A 75-year-old male with abdominal pain. An axial non-
contrast-enhanced CT image (a) of the abdomen demonstrates circum-
ferential homogeneous thickenin go ft h ea o r t i cw a l lu pt o5m m
corresponding to vivid circumferential 18-FDG uptake on PET-CT





Fig. 15 A 67-year-old female several months after ascending aneu-
rysm repair, with low-grade fever and malaise. Axial non-contrast-
enhanced (a) and contrast-enhanced (b) images of the chest demon-
strate an ascending aortic graft with surrounding minimal aortic wall
thickening (arrowheads in a and b respectively). The area was shown
to be positive for moderate 18-FDG uptake on the PET-CT image
(arrowhead in c). Blood cultures revealed Staphylococcus aureus
infection, concerning for infectious aortitis
Insights Imaging (2012) 3:545–560 557isolatedaortitis[82]Themale:femaleratiois2:3.Studieshave
shown that new aneurysms can develop in 25 % of patients
who did not receive anti-inflammatory therapy [83].
Infectious aortitis
The aorta is normally very resistant to infection; however, an
abnormal aortic wall, like that associated with atherosclerotic
disease, preexisting aneurysm, cystic medial necrosis, diabe-
tes, vascular malformation, medical devices or surgery, makes
it more susceptible to infection. The aetiologies vary. In the
antibiotic era the most frequent causative agents are Staphy-
lococcus aureus, Salmonella, Pneumococcus, Escherichia
coli, Treponema pallidum and other Treponema species (10–
25 years after the initial spirochetal infection), Candida, As-
pergillus and Tuberculosis [5]( F i g .15).
The spread of disease is usually contiguous, spread from
adjacent thoracic structures (mediastinitis, abscess, infected
lymph nodes, infectious pericarditis, empyema, paravertebral
abscess), although septic emboli from underlying bacterial
endocarditis or haematogenous dissemination of bacteria in
the setting of sepsis or intravenous drug abuse are not uncom-
mon [5, 84].
An ascending thoracic aorta, aortic arch and descending
thoracic aorta can all be affected, as well as prosthetic aortic
grafts and aortic homografts. Typically, sites of infected
aneurysms are opposite the great vessels in the aortic arch
or opposite the visceral arteries in the abdomen. Saccular
aneurysms are most common, but infected aneurysms can be
fusiform and often even pseudoaneurysms [5].
Imaging findings
Contrast-enhanced CT is the imaging modality of choice,
demonstrating aortic wall thickening, periaortic fluid or soft-
tissueaccumulation,rapidlyprogressingsaccularaneurysmor




mycotic aneurysm [5]. Pneumococcal aortitis is seen mainly
in the elderly secondary to bacteremia as well [86].
Tuberculous aortitis
This disorder is exceedingly rare and may mimic Takayasu
aortitis. To avoid delayed diagnosis or unnecessary immu-
nosuppressive therapy, this diagnosis should be considered
in patients with aortitis or atypical aortic aneurysm who
have a history of pulmonary or extrapulmonary tuberculosis
or who present with a cavitary lung lesion, pleural effusions
or lymphadenitis [24].
Usually the distal aortic arch and descending aorta are
involved, resulting from either direct extension from the
thoracic spine involved with tuberculous osteomyelitis, me-
diastinal lymph nodes, empyema or pericarditis, or from
haematogenous spread [5]. The association between verte-
bral tuberculosis and perforation is high, particularly with
the presence of a cold abscess [87].
Syphilitic aortitis
Though quite rare today, sexually transmitted diseases can
present as syphilitic aortitis, syphilitic aortic aneurysm, syphi-
litic aortic valvulitis with aortic regurgitation or syphilitic cor-
onary ostial stenosis. Chronic aortic inflammation results in
fibrosis and wrinkling of the intima with subsequent aneurysm
formation. Calcification of the ascending aorta is possible but
uncommon. The ascending thoracic aorta is most commonly
involved (60 %), followed by the aortic arch (30 %) [88].
Summary
Aortitis comprises a group of rare but important diseases, the
most common of which are Takayasu arteritis, giant cell
arteritis and Behçet's disease, predominantly seen in specific
areas, migration notwithstanding. Imaging is rarely used for
primary diagnosis but is important for the overall assessment
of the patient and for follow-up. The primary imaging method
iscontrast-enhancedCTwherethesediseasesclassicallyshow
abnormalities of wall thickness, vascular diameter and wall
density. Additional imaging can be performed with MRI, and
recently PET CT has been shown to be a helpful adjunct.
Radiologists should be familiar with the most common man-
ifestations of aortitis because imaging can be critical in the
initiation of appropriate management and therapy.
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